Skip to content

Breathing Exercise and Tele-Nursing Support for Patients With Tuberculosis: A Single-Group Experimental Study

The Effect of Breathing Exercise Education and Follow-Up Supported by Tele-Nursing on Dyspnea and Quality of Life in Patients With Tuberculosis: A Single-Group Experimental Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07069205
Acronym
TELEBREATH
Enrollment
54
Registered
2025-07-16
Start date
2025-01-10
Completion date
2025-04-11
Last updated
2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Quality of Life, Pulmonary Tuberculosis (TB)

Keywords

Tele-nursing, Dyspnea, Quality of life, Telehealth

Brief summary

This study was conducted as a single-group, pretest-posttest quasi-experimental design. The sample consisted of 54 tuberculosis patients registered at a Tuberculosis Dispensary who met the inclusion criteria and agreed to participate. Data collection tools included the Patient Identification Form, Dyspnea-12 TR Scale, Multidimensional Quality of Life Scale (MILQ), London Chest Activities of Daily Living Scale (LCADL), Tele-Nursing Follow-up Form, and Tele-Nursing Evaluation Form. Descriptive statistics, paired sample t-test, and Wilcoxon Signed-Rank Test were used for data analysis. The intervention group received structured respiratory exercises training, including abdominal breathing, pursed-lip breathing, and effective coughing, through educational materials (booklet and videos) developed by the researcher. Patients were regularly monitored for 12 weeks via phone calls and video conferencing. Baseline assessments were conducted using data collection tools at the first visit, and post-intervention assessments were performed at the end of week 12 to evaluate the effectiveness of the intervention.

Detailed description

This study implemented a structured respiratory exercise intervention supported by tele-nursing to assess its impact on dyspnea severity and quality of life among patients diagnosed with tuberculosis. The intervention included abdominal breathing, pursed-lip breathing, and effective coughing techniques delivered through a combination of printed educational booklets and instructional videos. These materials were specifically developed for the study and validated by expert healthcare professionals to ensure content accuracy and cultural appropriateness. Patients were monitored remotely over a 12-week period with scheduled weekly follow-up sessions conducted via telephone and video calls. These sessions facilitated reinforcement of the respiratory exercises, addressed patient inquiries, and enabled continuous assessment of adherence and response to the intervention. Data collection instruments, including validated Turkish versions of the Dyspnea-12 scale, the Multidimensional Quality of Life Scale (MILQ), and the London Chest Activities of Daily Living Scale (LCADL), were employed to quantitatively measure changes in respiratory symptoms, functional capacity, and overall quality of life. Comprehensive data management protocols were followed to ensure confidentiality and data integrity throughout the study period. Statistical analyses were performed using appropriate parametric and non-parametric tests based on data distribution, including paired-sample t-tests and Wilcoxon Signed-Rank tests, to evaluate the pre- and post-intervention effects. Ethical approval was obtained from the relevant institutional review board, and all participants provided informed consent prior to inclusion. This research contributes valuable insights into the feasibility and effectiveness of telehealth-supported respiratory therapy interventions in tuberculosis care, highlighting the potential of patient-centered, remotely delivered nursing practices to enhance treatment outcomes.

Interventions

BEHAVIORALTele-nursing supported respiratory exercises

This intervention consists of a structured tele-nursing supported respiratory exercise program including abdominal breathing, pursed-lip breathing, and effective coughing techniques. The training is delivered through educational booklets and videos over a 12-week period, aiming to improve respiratory function and patient self-management in tuberculosis patients.

Sponsors

Canan Güngör
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

open-label

Intervention model description

This study was conducted using a single-group pretest-posttest quasi-experimental design. All participants received the same structured respiratory exercise training and tele-nursing follow-up for 12 weeks.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with tuberculosis and registered at a Tuberculosis Dispensary. Meets criteria for study participation. Provides informed consent. Able to participate in tele-nursing supported respiratory exercises and follow-up.

Exclusion criteria

Severe respiratory comorbidities preventing exercise participation. Cognitive or communication impairments interfering with tele-nursing. Declines to participate or unable to comply with intervention protocol. \-

Design outcomes

Primary

MeasureTime frameDescription
Change in Dyspnea Severity Using the Dispne-12 Turkish Version ScaleBaseline and at 12 weeks post-interventionThis outcome measures the change in dyspnea severity in tuberculosis patients before and after receiving tele-nursing supported respiratory exercise training over 12 weeks, using the validated Dispne-12 TR scale.
Change in Dyspnea Severity (Dispne-12 TR Scale)Baseline (pre-intervention) and 12 weeks after the intervention.The change in dyspnea severity will be measured using the Dispne-12 Turkish version scale to assess the effectiveness of tele-nursing supported respiratory exercises on patients with tuberculosis over a 12-week period.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026